Go Pro

NCS Multistage (NCSM) Financials

NCS Multistage logo
$44.48 -1.49 (-3.24%)
Closing price 07/9/2026 04:00 PM Eastern
Extended Trading
$45.08 +0.61 (+1.36%)
As of 07/9/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for NCS Multistage

Annual Income Statements for NCS Multistage

This table shows NCS Multistage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
28 -18 2.10 -190 -33 -58 -4.73 -1.10 -3.15 6.59 24
Consolidated Net Income / (Loss)
28 -18 1.29 -185 -23 -39 -3.78 -0.95 -3.11 8.14 26
Net Income / (Loss) Continuing Operations
28 -18 1.29 -185 -23 -39 -3.78 -0.95 -3.11 8.14 26
Total Pre-Tax Income
12 -27 1.96 -208 -12 -47 -3.52 -0.60 -3.34 8.25 17
Total Operating Income
-5.78 -18 4.96 -207 -9.49 -71 -5.12 -2.25 -5.53 4.33 11
Total Gross Profit
59 45 103 119 97 44 48 60 56 67 75
Total Revenue
114 98 202 227 205 107 119 156 142 163 184
Operating Revenue
114 98 202 227 205 107 119 156 142 163 184
Total Cost of Revenue
55 54 99 108 108 63 70 95 87 95 108
Operating Cost of Revenue
55 54 99 108 108 63 70 - 87 95 108
Total Operating Expenses
65 63 98 325 107 116 54 63 61 63 65
Selling, General & Admin Expense
38 37 65 83 89 59 49 58 57 58 59
Depreciation Expense
2.70 1.77 3.19 4.75 5.88 4.43 3.83 3.65 3.95 4.60 4.99
Amortization Expense
25 24 24 13 4.56 1.47 0.67 0.67 0.67 0.72 0.89
Other Special Charges / (Income)
- - 5.53 -2.87 0.04 0.00 - - - 0.00 0.16
Total Other Income / (Expense), net
18 -8.76 -3.00 -1.62 -2.58 25 1.60 1.65 2.19 3.93 6.28
Interest & Investment Income
-8.06 -6.29 -4.31 -1.96 -1.93 -1.80 -0.73 -1.02 -0.59 -0.41 -0.25
Other Income / (Expense), net
26 -2.48 1.31 0.34 -0.65 26 2.34 2.67 2.77 4.34 6.53
Income Tax Expense
-16 -8.82 0.67 -23 11 -7.78 0.26 0.35 -0.23 0.12 -9.22
Net Income / (Loss) Attributable to Noncontrolling Interest
- - -0.81 5.09 10 18 0.96 0.15 0.04 1.55 2.29
Basic Earnings per Share
$0.88 ($0.53) $0.05 ($85.00) ($14.08) ($24.37) ($1.98) ($0.45) ($1.27) $2.60 $9.17
Weighted Average Basic Shares Outstanding
29.97M 34.01M 40.48M 2.24M 2.33M 2.36M 2.40M 2.43M 2.47M 2.54M 2.59M
Diluted Earnings per Share
$0.86 ($0.53) $0.05 ($85.00) ($14.08) ($24.37) ($1.98) ($0.45) ($1.27) $2.55 $8.65
Weighted Average Diluted Shares Outstanding
32.43M 34.01M 43.58M 2.24M 2.33M 2.36M 2.40M 2.43M 2.47M 2.59M 2.75M
Weighted Average Basic & Diluted Shares Outstanding
- - 42M 46.67M 46.81M 2.36M 2.41M 2.44M 2.49M 2.54M 2.55M

Quarterly Income Statements for NCS Multistage

This table shows NCS Multistage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
4.41 40 2.07 -3.10 4.15 3.47 4.06 0.92 3.81 15 -0.37
Consolidated Net Income / (Loss)
4.11 40 2.55 -2.84 4.70 3.72 4.45 1.70 4.24 16 1.74
Net Income / (Loss) Continuing Operations
4.11 40 2.55 -2.84 4.70 3.72 4.45 1.70 4.24 16 1.74
Total Pre-Tax Income
3.58 40 3.04 -2.57 4.67 3.11 5.13 0.67 3.69 7.33 2.58
Total Operating Income
1.87 -1.56 2.50 -4.15 3.04 2.94 4.29 -2.03 3.06 5.22 0.85
Total Gross Profit
16 13 18 12 19 19 22 13 19 21 18
Total Revenue
38 35 44 30 44 45 50 36 47 51 46
Operating Revenue
38 35 44 30 44 45 50 36 47 51 46
Total Cost of Revenue
23 22 26 18 25 26 28 23 27 29 27
Operating Cost of Revenue
23 22 26 18 25 26 28 23 27 29 27
Total Operating Expenses
14 14 15 16 15 16 18 15 16 16 17
Selling, General & Admin Expense
13 13 14 15 14 15 16 14 15 14 16
Depreciation Expense
1.00 1.06 1.07 1.13 1.19 1.21 1.20 1.24 1.28 1.28 1.29
Amortization Expense
0.17 0.17 0.17 0.17 0.17 0.21 0.17 0.17 0.26 0.30 0.30
Total Other Income / (Expense), net
1.70 41 0.54 1.58 1.63 0.18 0.84 2.70 0.63 2.12 1.73
Interest & Investment Income
-0.03 -0.14 -0.10 -0.12 -0.11 -0.09 -0.04 -0.07 -0.10 -0.04 -0.03
Other Income / (Expense), net
1.73 42 0.64 1.70 1.74 0.27 0.88 2.76 0.73 2.16 1.75
Income Tax Expense
-0.54 0.06 0.49 0.27 -0.04 -0.61 0.67 -1.03 -0.55 -8.31 0.83
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.30 0.21 0.48 0.26 0.56 0.25 0.40 0.77 0.43 0.68 2.11
Basic Earnings per Share
$1.78 $16.07 $0.83 ($1.21) $1.63 $1.35 $1.58 $0.36 $1.47 $5.76 ($0.14)
Weighted Average Basic Shares Outstanding
2.48M 2.47M 2.51M 2.55M 2.55M 2.54M 2.57M 2.59M 2.59M 2.59M 2.63M
Diluted Earnings per Share
$1.77 $16.08 $0.82 ($1.21) $1.60 $1.34 $1.51 $0.34 $1.37 $5.43 ($0.14)
Weighted Average Diluted Shares Outstanding
2.49M 2.47M 2.54M 2.55M 2.59M 2.59M 2.69M 2.73M 2.78M 2.75M 2.63M
Weighted Average Basic & Diluted Shares Outstanding
2.44M 2.49M 2.50M 2.50M 2.50M 2.54M 2.54M 2.54M 2.54M 2.55M 2.62M

Annual Cash Flow Statements for NCS Multistage

This table details how cash moves in and out of NCS Multistage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-11 8.73 16 -8.68 -14 4.30 6.62 -5.93 0.49 9.16 11
Net Cash From Operating Activities
4.37 11 16 14 18 35 12 -1.42 4.77 13 22
Net Cash From Continuing Operating Activities
4.37 11 16 14 18 35 12 -1.42 4.77 13 22
Net Income / (Loss) Continuing Operations
28 -18 1.29 -185 -23 -39 -3.78 -0.95 -3.11 8.14 26
Consolidated Net Income / (Loss)
28 -18 1.29 -185 -23 -39 -3.78 -0.95 -3.11 8.14 26
Depreciation Expense
27 26 28 18 10 5.89 4.50 4.32 4.62 5.32 5.89
Amortization Expense
0.95 0.74 0.44 0.33 0.31 0.30 0.28 0.23 0.20 0.21 0.22
Non-Cash Adjustments To Reconcile Net Income
-23 6.20 5.74 241 22 57 8.15 8.95 7.08 8.31 4.85
Changes in Operating Assets and Liabilities, net
-29 -3.90 -19 -59 8.52 11 2.43 -14 -4.02 -9.25 -15
Net Cash From Investing Activities
-1.22 -1.84 -85 -15 -5.00 -1.06 -0.44 -0.70 -1.68 0.48 -6.29
Net Cash From Continuing Investing Activities
-1.22 -1.84 -85 -15 -5.00 -1.06 -0.44 -0.70 -1.68 0.48 -6.29
Purchase of Property, Plant & Equipment
-0.89 -1.16 -5.42 -16 -6.37 -2.15 -0.83 -1.13 -1.88 -1.31 -1.20
Acquisitions
- - -81 - - - - - -0.31 -0.07 -5.86
Sale of Property, Plant & Equipment
0.42 0.32 0.35 0.40 1.37 1.09 0.39 0.43 0.51 0.59 0.77
Other Investing Activities, net
-0.76 - - - - - - - 0.00 1.27 0.00
Net Cash From Financing Activities
-13 -0.32 84 -5.13 -27 -30 -4.27 -2.74 -2.44 -4.27 -5.30
Net Cash From Continuing Financing Activities
-13 -0.32 84 -5.13 -27 -30 -4.27 -2.74 -2.44 -4.27 -5.30
Repayment of Debt
-53 - -96 -11 -16 -17 -1.68 -14 -12 -3.06 -2.39
Payment of Dividends
- - - -2.30 -6.00 -18 -2.75 0.00 -0.50 -2.05 -2.70
Issuance of Debt
- - 30 7.35 0.00 5.00 0.36 12 12 3.06 2.34
Other Financing Activities, net
- - 1.54 0.92 -6.44 -0.16 -0.20 -0.38 -1.89 -2.22 -2.55
Other Net Changes in Cash
- - - - - - - - -0.16 0.23 0.27
Cash Interest Paid
9.38 5.45 3.02 1.37 1.07 0.93 0.42 0.56 0.38 0.17 0.08
Cash Income Taxes Paid
20 0.13 4.03 22 0.12 -1.92 -3.53 -0.30 -0.14 0.43 1.61

Quarterly Cash Flow Statements for NCS Multistage

This table details how cash moves in and out of NCS Multistage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-2.35 5.32 -2.72 4.61 -3.28 11 -2.88 2.38 -0.08 11 -2.27
Net Cash From Operating Activities
-0.40 6.22 -1.88 5.98 -2.02 11 -1.65 3.52 7.17 13 1.28
Net Cash From Continuing Operating Activities
-0.40 6.22 -1.88 5.98 -2.02 11 -1.65 3.52 7.17 13 1.28
Net Income / (Loss) Continuing Operations
4.11 40 2.55 -2.84 4.70 3.72 4.45 1.70 4.24 16 1.74
Consolidated Net Income / (Loss)
4.11 40 2.55 -2.84 4.70 3.72 4.45 1.70 4.24 16 1.74
Depreciation Expense
1.17 1.22 1.24 1.30 1.36 1.42 1.37 1.40 1.54 1.58 1.60
Amortization Expense
0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.06 0.06
Non-Cash Adjustments To Reconcile Net Income
1.95 -40 1.48 1.93 1.53 3.37 0.57 0.15 1.28 2.84 1.34
Changes in Operating Assets and Liabilities, net
-7.68 4.87 -7.20 5.53 -9.66 2.09 -8.09 0.22 0.06 -6.99 -3.46
Net Cash From Investing Activities
-0.54 -0.17 -0.14 -0.26 -0.34 1.21 -0.45 -0.02 -5.59 -0.23 -0.56
Net Cash From Continuing Investing Activities
-0.54 -0.17 -0.14 -0.26 -0.34 1.21 -0.45 -0.02 -5.59 -0.23 -0.56
Purchase of Property, Plant & Equipment
-0.55 -0.18 -0.30 -0.33 -0.45 -0.23 -0.46 -0.28 -0.23 -0.23 -0.59
Acquisitions
-0.10 -0.05 -0.01 -0.04 -0.02 - 0.00 - -5.82 -0.05 -0.05
Sale of Property, Plant & Equipment
0.11 0.06 0.18 0.12 0.13 0.17 0.01 0.26 0.46 0.04 0.08
Net Cash From Financing Activities
-1.21 -0.96 -0.63 -1.04 -1.01 -1.59 -0.79 -1.45 -1.55 -1.51 -2.94
Net Cash From Continuing Financing Activities
-1.21 -0.96 -0.63 -1.04 -1.01 -1.59 -0.79 -1.45 -1.55 -1.51 -2.94
Repayment of Debt
-4.10 - -0.60 -2.37 -0.09 - -1.96 -0.38 - -0.06 -1.97
Issuance of Debt
3.31 - 1.16 1.82 0.09 - 1.96 0.38 - - 1.97
Other Financing Activities, net
-0.42 -0.46 -0.69 -0.48 -0.51 -0.54 -0.79 -0.55 -0.55 -0.65 -2.94
Other Net Changes in Cash
-0.20 0.23 - - 0.08 0.29 0.00 - - - -0.05

Annual Balance Sheets for NCS Multistage

This table presents NCS Multistage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
327 464 230 203 139 142 139 152 153 181
Total Current Assets
75 118 115 101 84 88 88 103 106 122
Cash & Equivalents
18 34 25 11 16 22 16 17 26 37
Accounts Receivable
35 49 55 47 30 29 32 28 37 44
Inventories, net
17 33 33 40 35 34 37 42 41 39
Prepaid Expenses
2.45 1.62 2.04 2.44 2.98 3.29 2.82 1.86 2.06 2.03
Plant, Property, & Equipment, net
9.76 24 32 33 24 25 23 0.00 0.00 0.00
Total Noncurrent Assets
242 322 83 69 31 29 28 49 47 59
Goodwill
122 184 23 15 15 15 15 15 15 16
Intangible Assets
119 136 49 45 6.41 5.74 5.08 4.41 3.69 5.99
Noncurrent Deferred & Refundable Income Taxes
- - 9.33 0.01 0.21 0.24 0.05 0.07 0.42 12
Other Noncurrent Operating Assets
1.27 1.56 1.39 8.53 8.73 7.92 7.28 29 27 25
Total Liabilities & Shareholders' Equity
327 464 230 203 139 142 139 152 153 181
Total Liabilities
149 95 53 39 25 32 29 43 37 38
Total Current Liabilities
18 32 26 20 15 20 18 32 25 29
Short-Term Debt
0.77 5.33 12 1.48 1.35 1.48 1.49 1.81 2.14 3.64
Accounts Payable
10 7.45 7.17 8.55 4.94 7.50 7.55 6.23 8.97 8.52
Accrued Expenses
3.29 6.67 4.08 3.45 3.35 6.32 4.39 3.70 8.35 9.46
Current Deferred & Payable Income Tax Liabilities
- 11 0.18 1.88 0.65 0.29 0.47 0.36 0.68 1.15
Other Current Liabilities
3.22 1.67 1.99 4.42 4.59 4.22 3.80 20 5.27 5.76
Total Noncurrent Liabilities
132 63 28 19 10 12 12 11 11 9.58
Long-Term Debt
88 22 23 11 4.44 6.34 6.44 6.34 6.00 5.26
Noncurrent Deferred & Payable Income Tax Liabilities
43 24 3.13 2.96 0.01 0.11 0.20 0.25 0.19 0.40
Other Noncurrent Operating Liabilities
0.72 17 1.26 4.86 5.85 5.39 5.01 3.99 5.10 3.92
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
177 369 176 164 113 111 109 109 116 143
Total Preferred & Common Equity
177 357 161 145 94 93 91 92 99 126
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
177 357 161 145 94 93 91 92 99 126
Common Stock
238 400 412 425 433 437 440 445 447 450
Retained Earnings
22 24 -166 -199 -257 -261 -262 -266 -259 -235
Treasury Stock
-0.18 -0.18 -0.34 -0.65 -0.81 -1.01 -1.39 -1.68 -1.94 -2.27
Accumulated Other Comprehensive Income / (Loss)
-82 -67 -84 -81 -82 -82 -86 -86 -88 -86
Noncontrolling Interest
- 12 15 19 20 18 18 18 17 17

Quarterly Balance Sheets for NCS Multistage

This table presents NCS Multistage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
142 141 139 146 155 158 162 175
Total Current Assets
90 93 92 99 109 111 111 117
Cash & Equivalents
11 14 19 15 23 25 25 34
Accounts Receivable
34 38 28 41 43 39 39 40
Inventories, net
42 39 42 41 41 44 44 41
Prepaid Expenses
2.34 1.70 3.21 2.00 1.85 2.71 2.48 1.70
Plant, Property, & Equipment, net
24 23 23 23 0.00 0.00 0.00 0.00
Total Noncurrent Assets
27 24 24 23 45 46 50 57
Goodwill
15 15 15 15 15 15 16 16
Intangible Assets
4.57 4.24 4.07 3.91 3.52 3.36 6.29 5.69
Noncurrent Deferred & Refundable Income Taxes
0.26 0.07 0.20 0.19 0.42 1.87 2.20 11
Other Noncurrent Operating Assets
7.20 4.46 4.06 3.64 26 26 25 24
Total Liabilities & Shareholders' Equity
142 141 139 146 155 158 162 175
Total Liabilities
73 29 30 32 34 34 35 31
Total Current Liabilities
20 19 20 22 24 24 25 22
Short-Term Debt
1.76 2.44 2.07 2.11 2.25 2.20 3.40 2.29
Accounts Payable
9.40 8.49 7.57 7.51 12 10.00 7.92 11
Accrued Expenses
5.07 3.81 5.41 6.87 5.35 6.80 8.40 4.88
Current Deferred & Payable Income Tax Liabilities
0.02 0.35 0.74 0.71 1.10 0.79 0.29 0.97
Other Current Liabilities
3.59 4.10 4.15 4.90 3.41 4.02 5.35 3.17
Total Noncurrent Liabilities
53 10 10 9.62 10 10 9.55 8.90
Long-Term Debt
6.54 6.44 6.83 6.53 5.37 5.46 5.11 4.91
Noncurrent Deferred & Payable Income Tax Liabilities
0.49 0.24 0.37 0.31 0.18 0.19 0.17 0.41
Other Noncurrent Operating Liabilities
46 3.57 3.19 2.79 4.87 4.54 4.27 3.59
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
69 111 109 114 121 124 127 144
Total Preferred & Common Equity
51 94 91 96 103 106 110 125
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
51 94 91 96 103 106 110 125
Common Stock
444 445 446 447 448 449 449 450
Retained Earnings
-305 -264 -267 -262 -255 -254 -250 -236
Treasury Stock
-1.65 -1.91 -1.91 -1.91 -2.21 -2.21 -2.21 -3.34
Accumulated Other Comprehensive Income / (Loss)
-86 -86 -87 -86 -88 -86 -87 -87
Noncontrolling Interest
18 18 18 18 18 18 17 19

Annual Metrics And Ratios for NCS Multistage

This table displays calculated financial ratios and metrics derived from NCS Multistage's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 43,911,636.00 45,010,626.00 46,813,117.00 47,198,367.00 2,380,374.00 2,408,474.00 2,439,126.00 2,502,812.00 2,540,920.00
DEI Adjusted Shares Outstanding
0.00 0.00 2,195,582.00 2,250,531.00 2,340,656.00 2,359,918.00 2,380,374.00 2,408,474.00 2,439,126.00 2,502,812.00 2,540,920.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.96 -84.57 -14.02 -24.41 -1.99 -0.46 -1.29 2.63 9.35
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -13.62% 104.75% 12.56% -9.46% -47.94% 10.77% 31.33% -8.46% 14.10% 12.96%
EBITDA Growth
0.00% -87.84% 487.60% -647.53% 100.32% -6,509.56% 105.14% 148.32% -58.44% 587.93% 63.27%
EBIT Growth
0.00% -202.99% 130.64% -3,391.64% 95.08% -344.66% 93.83% 114.88% -765.94% 414.40% 96.94%
NOPAT Growth
0.00% 8.35% 125.94% -4,530.02% 95.41% -652.71% 92.83% 56.00% -145.49% 210.14% 282.62%
Net Income Growth
0.00% -163.97% 107.21% -14,436.76% 87.68% -71.38% 90.34% 74.81% -226.79% 361.59% 219.94%
EPS Growth
0.00% -161.63% 109.43% -14,436.76% 87.68% -73.08% 91.88% 77.27% -182.22% 300.79% 239.22%
Operating Cash Flow Growth
0.00% 144.54% 50.82% -12.96% 27.97% 95.65% -67.02% -112.29% 435.49% 166.55% 74.26%
Free Cash Flow Firm Growth
0.00% 0.00% 57.62% 127.85% -51.65% -22.90% -66.65% -262.29% 39.71% 298.42% -109.50%
Invested Capital Growth
0.00% 0.00% 45.84% -48.44% -11.53% -37.22% -7.15% 4.81% -0.12% -3.14% 17.43%
Revenue Q/Q Growth
0.00% 0.00% 7.89% 0.00% -15.56% 16.38% 7.96% 2.69% -3.35% 6.38% 3.16%
EBITDA Q/Q Growth
0.00% 0.00% -9.76% -602.78% 100.27% 37.83% -92.23% 24.66% 105.96% -72.08% 23.01%
EBIT Q/Q Growth
0.00% 0.00% -41.15% -1,336.71% 95.75% 35.83% -113.27% 163.30% 92.99% -80.95% 32.33%
NOPAT Q/Q Growth
0.00% 0.00% -40.98% -1,064.70% 96.03% -1.97% 37.70% 19.04% -155.71% 2,698.24% 76.36%
Net Income Q/Q Growth
0.00% 0.00% -69.33% -1,529.14% 89.85% 37.85% -120.93% 23.66% 92.35% -81.62% 84.48%
EPS Q/Q Growth
0.00% 0.00% -54.55% -1,529.14% 89.85% 15.56% -317.58% 22.41% 92.28% -85.25% 89.69%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 151.11% -32.76% 59.89% 27.04% -57.62% 65.91% -22.59% 53.28% 12.64%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 773.61% -72.91% -57.73% 159.52% 13.91% -110.33% 118.04% -111.49%
Invested Capital Q/Q Growth
0.00% 0.00% -3.78% -52.84% -4.84% 6.47% -1.82% -2.34% 53.74% -8.42% 4.50%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.01% 45.34% 51.00% 52.28% 47.43% 41.20% 40.91% 38.81% 39.03% 41.50% 41.08%
EBITDA Margin
42.17% 5.94% 17.04% -82.90% 0.30% -36.37% 1.69% 3.19% 1.45% 8.73% 12.62%
Operating Margin
-5.07% -18.26% 2.46% -91.06% -4.62% -66.78% -4.32% -1.45% -3.88% 2.66% 5.74%
EBIT Margin
17.42% -20.78% 3.11% -90.90% -4.94% -42.15% -2.35% 0.27% -1.94% 5.33% 9.30%
Profit (Net Income) Margin
24.58% -18.20% 0.64% -81.61% -11.10% -36.56% -3.19% -0.61% -2.18% 5.01% 14.18%
Tax Burden Percent
237.48% 67.03% 65.85% 88.93% 189.11% 83.40% 107.48% 158.40% 93.06% 98.59% 154.80%
Interest Burden Percent
59.41% 130.72% 31.30% 100.95% 118.98% 103.98% 126.34% -145.17% 121.26% 95.22% 98.53%
Effective Tax Rate
-137.48% 0.00% 34.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.41% -54.80%
Return on Invested Capital (ROIC)
0.00% -10.14% 1.07% -52.70% -3.78% -37.19% -3.58% -1.60% -3.84% 4.30% 15.37%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -25.20% -5.09% -2,216.23% -268.99% -306.97% -1.97% -7.12% -12.85% -24.38% -26.12%
Return on Net Nonoperating Assets (RNNOA)
0.00% -10.07% -0.60% -15.24% -9.66% 8.96% 0.21% 0.73% 0.99% 2.92% 4.72%
Return on Equity (ROE)
0.00% -20.20% 0.47% -67.95% -13.43% -28.23% -3.37% -0.87% -2.85% 7.22% 20.09%
Cash Return on Invested Capital (CROIC)
0.00% -210.14% -36.22% 11.22% 8.46% 8.54% 3.83% -6.30% -3.71% 7.49% -0.67%
Operating Return on Assets (OROA)
0.00% -6.26% 1.59% -59.49% -4.69% -26.43% -1.98% 0.29% -1.90% 5.69% 10.22%
Return on Assets (ROA)
0.00% -5.49% 0.33% -53.41% -10.56% -22.92% -2.69% -0.68% -2.14% 5.34% 15.59%
Return on Common Equity (ROCE)
0.00% -20.20% 0.46% -64.57% -12.09% -24.28% -2.80% -0.72% -2.38% 6.10% 17.44%
Return on Equity Simple (ROE_SIMPLE)
0.00% -10.10% 0.36% -114.84% -15.78% -41.78% -4.08% -1.05% -3.40% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-14 -13 3.27 -145 -6.64 -50 -3.58 -1.58 -3.87 4.26 16
NOPAT Margin
-12.05% -12.78% 1.62% -63.74% -3.23% -46.75% -3.02% -1.01% -2.72% 2.62% 8.89%
Net Nonoperating Expense Percent (NNEP)
0.00% 15.06% 6.16% 2,163.53% 265.22% 269.78% -1.62% 5.52% 9.02% 28.68% 41.48%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -3.29% 3.43% 10.73%
Cost of Revenue to Revenue
47.99% 54.66% 49.00% 47.72% 52.57% 58.80% 59.09% 61.19% 60.97% 58.50% 58.92%
SG&A Expenses to Revenue
33.16% 37.63% 32.09% 36.49% 43.10% 55.55% 41.43% 37.48% 39.67% 35.57% 32.05%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
57.08% 63.60% 48.54% 143.34% 52.05% 107.98% 45.23% 40.26% 42.91% 38.84% 35.34%
Earnings before Interest and Taxes (EBIT)
20 -20 6.27 -206 -10 -45 -2.78 0.41 -2.76 8.67 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
48 5.85 34 -188 0.61 -39 2.00 4.96 2.06 14 23
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.81 1.42 0.68 0.57 0.75 0.66 0.48 0.66 0.79
Price to Tangible Book Value (P/TBV)
0.00 0.00 18.00 2.57 1.17 0.74 0.96 0.85 0.60 0.81 0.97
Price to Revenue (P/Rev)
0.00 0.00 3.21 1.01 0.48 0.50 0.58 0.39 0.31 0.40 0.55
Price to Earnings (P/E)
0.00 0.00 307.92 0.00 0.00 0.00 0.00 0.00 0.00 9.85 4.23
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.32% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.15% 23.67%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.80 1.36 0.72 0.61 0.76 0.69 0.52 0.66 0.78
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 3.24 1.12 0.58 0.59 0.61 0.45 0.37 0.40 0.49
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 18.99 0.00 195.91 0.00 36.39 14.13 25.57 4.55 3.86
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 104.12 0.00 0.00 0.00 0.00 169.41 0.00 7.44 5.24
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 199.85 0.00 0.00 0.00 0.00 0.00 0.00 15.13 5.48
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 40.50 18.15 6.63 1.80 6.28 0.00 11.05 5.07 4.03
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 8.27 7.99 5.51 19.00 0.00 0.00 8.68 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.50 0.07 0.20 0.08 0.05 0.07 0.07 0.07 0.07 0.06
Long-Term Debt to Equity
0.00 0.50 0.06 0.13 0.07 0.04 0.06 0.06 0.06 0.05 0.04
Financial Leverage
0.00 0.40 0.12 0.01 0.04 -0.03 -0.11 -0.10 -0.08 -0.12 -0.18
Leverage Ratio
0.00 1.84 1.45 1.27 1.27 1.23 1.25 1.28 1.33 1.35 1.29
Compound Leverage Factor
0.00 2.41 0.45 1.28 1.51 1.28 1.58 -1.85 1.61 1.29 1.27
Debt to Total Capital
0.00% 33.44% 6.83% 16.83% 7.32% 4.85% 6.60% 6.76% 6.94% 6.55% 5.85%
Short-Term Debt to Total Capital
0.00% 0.29% 1.35% 5.76% 0.84% 1.13% 1.25% 1.27% 1.54% 1.72% 2.39%
Long-Term Debt to Total Capital
0.00% 33.15% 5.48% 11.07% 6.48% 3.72% 5.35% 5.49% 5.40% 4.83% 3.46%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 3.07% 7.05% 10.73% 16.67% 15.26% 15.56% 15.12% 13.90% 11.09%
Common Equity to Total Capital
0.00% 66.56% 90.11% 76.13% 81.95% 78.48% 78.14% 77.68% 77.94% 79.55% 83.06%
Debt to EBITDA
0.00 15.25 0.79 -0.19 21.28 -0.15 3.91 1.60 3.95 0.57 0.38
Net Debt to EBITDA
0.00 12.12 -0.20 -0.06 2.76 0.25 -7.18 -1.67 -4.15 -1.25 -1.20
Long-Term Debt to EBITDA
0.00 15.12 0.63 -0.12 18.84 -0.11 3.17 1.30 3.08 0.42 0.23
Debt to NOPAT
0.00 -7.08 8.28 -0.25 -1.94 -0.12 -2.18 -5.03 -2.11 1.91 0.55
Net Debt to NOPAT
0.00 -5.63 -2.07 -0.07 -0.25 0.20 4.00 5.27 2.21 -4.16 -1.71
Long-Term Debt to NOPAT
0.00 -7.02 6.65 -0.16 -1.72 -0.09 -1.77 -4.08 -1.64 1.41 0.32
Altman Z-Score
0.00 0.00 4.87 0.05 1.46 -1.03 0.08 0.32 -0.39 0.57 1.71
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 2.22% 4.97% 9.97% 14.01% 16.94% 16.51% 16.47% 15.54% 13.17%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 4.28 3.72 4.47 5.09 5.62 4.47 4.95 3.22 4.15 4.27
Quick Ratio
0.00 3.05 2.62 3.11 2.94 3.08 2.59 2.70 1.40 2.46 2.84
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -261 -111 31 15 11 3.83 -6.21 -3.75 7.43 -0.71
Operating Cash Flow to CapEx
937.55% 1,271.90% 318.08% 91.02% 358.84% 3,316.05% 2,608.78% -203.87% 347.71% 1,774.76% 5,169.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.30 0.51 0.65 0.95 0.63 0.84 1.11 0.98 1.07 1.10
Accounts Receivable Turnover
0.00 2.80 4.78 4.37 4.04 2.77 3.99 5.13 4.78 5.03 4.54
Inventory Turnover
0.00 3.16 3.94 3.29 2.97 1.68 2.04 2.68 2.21 2.30 2.71
Fixed Asset Turnover
0.00 10.09 12.07 8.11 6.30 3.73 4.82 6.48 0.00 0.00 0.00
Accounts Payable Turnover
0.00 5.25 11.16 14.82 13.75 9.33 11.25 12.65 12.61 12.52 12.38
Days Sales Outstanding (DSO)
0.00 130.35 76.41 83.56 90.29 131.82 91.48 71.17 76.34 72.61 80.31
Days Inventory Outstanding (DIO)
0.00 115.38 92.65 111.02 122.77 216.98 179.27 135.99 165.24 158.49 134.90
Days Payable Outstanding (DPO)
0.00 69.55 32.71 24.63 26.55 39.14 32.43 28.84 28.94 29.16 29.49
Cash Conversion Cycle (CCC)
0.00 176.18 136.35 169.96 186.51 309.66 238.32 178.31 212.64 201.94 185.72
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 248 362 187 165 104 96 101 101 98 115
Invested Capital Turnover
0.00 0.79 0.66 0.83 1.17 0.80 1.18 1.58 1.41 1.64 1.73
Increase / (Decrease) in Invested Capital
0.00 248 114 -175 -22 -61 -7.41 4.64 -0.13 -3.17 17
Enterprise Value (EV)
0.00 0.00 653 255 119 63 73 70 53 65 89
Market Capitalization
0.00 0.00 647 229 98 53 69 60 44 65 100
Book Value per Share
$0.00 $5.22 $8.13 $3.58 $3.09 $1.98 $38.89 $37.80 $37.56 $39.49 $49.68
Tangible Book Value per Share
$0.00 ($1.86) $0.82 $1.98 $1.80 $1.52 $30.09 $29.37 $29.51 $31.93 $40.88
Total Capital
0.00 267 396 212 176 119 118 117 118 124 152
Total Debt
0.00 89 27 36 13 5.79 7.82 7.93 8.16 8.14 8.89
Total Long-Term Debt
0.00 88 22 23 11 4.44 6.34 6.44 6.34 6.00 5.26
Net Debt
0.00 71 -6.77 11 1.67 -9.76 -14 -8.31 -8.56 -18 -28
Capital Expenditures (CapEx)
0.47 0.84 5.07 15 5.00 1.06 0.44 0.70 1.37 0.72 0.43
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 40 58 76 71 55 48 55 56 56 60
Debt-free Net Working Capital (DFNWC)
0.00 58 91 101 82 70 70 71 73 82 97
Net Working Capital (NWC)
0.00 57 86 89 81 69 69 70 71 80 93
Net Nonoperating Expense (NNE)
-42 5.34 1.97 41 16 -11 0.20 -0.63 -0.76 -3.87 -9.72
Net Nonoperating Obligations (NNO)
0.00 71 -6.77 11 1.67 -9.76 -14 -8.31 -8.56 -18 -28
Total Depreciation and Amortization (D&A)
28 26 28 18 11 6.19 4.78 4.55 4.82 5.52 6.10
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 40.59% 28.59% 33.50% 34.58% 51.03% 40.50% 35.48% 39.48% 34.70% 32.84%
Debt-free Net Working Capital to Revenue
0.00% 59.15% 45.36% 44.57% 40.05% 65.56% 59.20% 45.92% 51.22% 50.62% 52.84%
Net Working Capital to Revenue
0.00% 58.37% 42.71% 39.20% 39.33% 64.30% 57.95% 44.96% 49.95% 49.31% 50.86%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$17.60 ($10.60) $1.00 ($85.00) ($14.00) ($24.37) ($1.98) ($0.45) ($1.27) $2.60 $9.17
Adjusted Weighted Average Basic Shares Outstanding
1.50M 1.70M 2.02M 2.24M 2.33M 2.36M 2.40M 2.43M 2.47M 2.54M 2.59M
Adjusted Diluted Earnings per Share
$17.20 ($10.60) $1.00 ($85.00) ($14.00) ($24.37) ($1.98) ($0.45) ($1.27) $2.55 $8.65
Adjusted Weighted Average Diluted Shares Outstanding
1.62M 1.70M 2.18M 2.24M 2.33M 2.36M 2.40M 2.43M 2.47M 2.59M 2.75M
Adjusted Basic & Diluted Earnings per Share
$17.60 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 2.22M 2.33M 2.34M 2.36M 2.41M 2.44M 2.49M 2.54M 2.55M
Normalized Net Operating Profit after Tax (NOPAT)
-4.05 -13 6.90 13 -1.07 -15 -3.58 -1.58 -3.87 4.26 7.49
Normalized NOPAT Margin
-3.55% -12.78% 3.42% 5.55% -0.52% -13.90% -3.02% -1.01% -2.72% 2.62% 4.08%
Pre Tax Income Margin
10.35% -27.16% 0.97% -91.77% -5.87% -43.83% -2.97% -0.39% -2.35% 5.08% 9.16%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% -1.24% -26.30% -44.88% -72.77% 0.00% -16.07% 25.19% 10.37%
Augmented Payout Ratio
0.00% -2.33% 168.58% -1.24% -26.30% -44.88% -72.77% 0.00% -16.07% 25.19% 10.37%

Quarterly Metrics And Ratios for NCS Multistage

This table displays calculated financial ratios and metrics derived from NCS Multistage's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
2,438,994.00 2,439,126.00 2,485,708.00 2,502,564.00 2,502,680.00 2,502,812.00 2,540,849.00 2,540,849.00 2,540,849.00 2,540,920.00 2,545,535.00
DEI Adjusted Shares Outstanding
2,438,994.00 2,439,126.00 2,485,708.00 2,502,564.00 2,502,680.00 2,502,812.00 2,540,849.00 2,540,849.00 2,540,849.00 2,540,920.00 2,545,535.00
DEI Earnings Per Adjusted Shares Outstanding
1.81 16.25 0.83 -1.24 1.66 1.39 1.60 0.36 1.50 5.89 -0.15
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-21.67% -12.29% 0.70% 16.93% 14.96% 27.68% 14.02% 22.78% 5.75% 12.50% -8.74%
EBITDA Growth
-6.37% 795.84% 130.09% 96.25% 28.27% -88.68% 48.77% 298.73% -13.03% 92.69% -35.41%
EBIT Growth
-11.02% 1,048.68% 119.76% 91.96% 32.62% -92.00% 64.62% 129.91% -20.62% 130.14% -49.68%
NOPAT Growth
-48.35% -222.07% 134.41% 41.80% 41.95% 325.94% 77.40% -78.16% 14.99% 217.22% -84.61%
Net Income Growth
3.73% 1,639.37% 117.02% 91.15% 14.40% -90.66% 74.46% 159.81% -9.82% 320.51% -60.91%
EPS Growth
12.03% 1,885.19% 113.44% 90.71% -9.60% -91.67% 84.15% 128.10% -14.38% 305.22% -109.27%
Operating Cash Flow Growth
89.47% -18.30% -21.21% 1,074.66% -399.26% 71.11% 12.50% -41.11% 455.38% 23.38% 177.81%
Free Cash Flow Firm Growth
3,742.46% 57.57% -201.02% -227.69% -195.11% 567.73% 131.96% 70.79% 101.09% -188.23% -341.32%
Invested Capital Growth
-36.56% -0.12% 17.76% 66.30% 62.59% -3.14% -0.65% 7.25% 2.91% 17.43% 10.71%
Revenue Q/Q Growth
50.76% -7.92% 24.43% -32.30% 48.22% 2.27% 11.11% -27.10% 27.66% 8.79% -9.86%
EBITDA Q/Q Growth
116.43% 756.82% -89.28% -124.85% 661.76% -24.38% 40.95% -66.81% 145.84% 67.54% -52.75%
EBIT Q/Q Growth
111.80% 1,011.69% -92.16% -178.15% 294.66% -32.91% 61.28% -85.80% 416.62% 94.51% -64.74%
NOPAT Q/Q Growth
143.19% -172.04% 235.26% -238.31% 205.33% 14.67% 6.20% -238.90% 167.98% 216.33% -94.85%
Net Income Q/Q Growth
112.82% 869.09% -93.59% -211.20% 265.69% -20.92% 19.73% -61.88% 149.82% 268.76% -88.87%
EPS Q/Q Growth
113.59% 808.47% -94.90% -247.56% 232.23% -16.25% 12.69% -77.48% 302.94% 296.35% -102.58%
Operating Cash Flow Q/Q Growth
-179.37% 1,639.60% -130.23% 418.03% -133.73% 627.66% -115.46% 314.04% 103.58% 83.19% -90.25%
Free Cash Flow Firm Q/Q Growth
20.94% -103.57% -867.16% -205.40% 9.92% 117.58% -33.92% -379.14% 103.36% -1,525.52% -80.74%
Invested Capital Q/Q Growth
10.72% 53.74% 4.62% -6.62% 8.26% -8.42% 7.31% 0.81% 3.88% 4.50% 1.17%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
41.05% 36.56% 40.06% 40.32% 42.11% 43.08% 43.71% 35.66% 41.71% 41.79% 39.82%
EBITDA Margin
12.60% 117.22% 10.10% -3.71% 14.05% 10.39% 13.18% 6.00% 11.56% 17.80% 9.33%
Operating Margin
4.90% -4.41% 5.70% -13.98% 6.90% 6.53% 8.58% -5.57% 6.58% 10.31% 1.86%
EBIT Margin
9.41% 113.61% 7.16% -8.27% 10.86% 7.12% 10.34% 2.01% 8.15% 14.57% 5.70%
Profit (Net Income) Margin
10.74% 113.06% 5.82% -9.56% 10.69% 8.27% 8.91% 4.66% 9.12% 30.90% 3.81%
Tax Burden Percent
115.02% 99.86% 83.98% 110.51% 100.75% 119.46% 86.87% 254.96% 114.87% 213.29% 67.61%
Interest Burden Percent
99.25% 99.65% 96.82% 104.69% 97.74% 97.16% 99.19% 90.74% 97.39% 99.43% 99.00%
Effective Tax Rate
-15.02% 0.14% 16.02% 0.00% -0.75% -19.46% 13.13% -154.96% -14.87% -113.29% 32.39%
Return on Invested Capital (ROIC)
9.83% -6.22% 7.01% -18.25% 12.34% 12.77% 11.96% -24.41% 12.44% 38.02% 2.04%
ROIC Less NNEP Spread (ROIC-NNEP)
-66.18% -497.00% -1.05% -19.10% -18.77% 11.20% 5.35% -72.03% 6.61% 18.76% -3.29%
Return on Net Nonoperating Assets (RNNOA)
1.96% 38.35% 0.06% 1.71% 1.09% -1.34% -0.51% 8.92% -0.68% -3.39% 0.54%
Return on Equity (ROE)
11.78% 32.13% 7.07% -16.53% 13.42% 11.43% 11.45% -15.48% 11.76% 34.63% 2.58%
Cash Return on Invested Capital (CROIC)
42.94% -3.71% -20.35% -51.47% -47.86% 7.49% 6.30% 1.66% 5.68% -0.67% 0.35%
Operating Return on Assets (OROA)
9.95% 111.38% 7.24% -8.78% 11.54% 7.60% 11.78% 2.38% 9.42% 16.02% 6.20%
Return on Assets (ROA)
11.36% 110.84% 5.89% -10.16% 11.36% 8.82% 10.15% 5.50% 10.54% 33.97% 4.15%
Return on Common Equity (ROCE)
9.35% 26.84% 5.84% -13.06% 10.77% 9.65% 9.70% -13.12% 10.05% 30.07% 2.23%
Return on Equity Simple (ROE_SIMPLE)
-80.34% 0.00% 15.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
2.16 -1.55 2.10 -2.91 3.06 3.51 3.73 -5.18 3.52 11 0.57
NOPAT Margin
5.63% -4.41% 4.79% -9.78% 6.95% 7.80% 7.45% -14.20% 7.56% 21.98% 1.26%
Net Nonoperating Expense Percent (NNEP)
76.01% 490.78% 8.06% 0.85% 31.11% 1.57% 6.61% 47.62% 5.83% 19.26% 5.33%
Return On Investment Capital (ROIC_SIMPLE)
- -1.32% 1.75% -2.46% 2.49% 2.82% 2.90% -3.93% 2.59% 7.32% 0.38%
Cost of Revenue to Revenue
58.95% 63.44% 59.94% 59.68% 57.89% 56.92% 56.29% 64.34% 58.29% 58.21% 60.18%
SG&A Expenses to Revenue
33.10% 37.51% 31.53% 49.92% 32.13% 33.40% 32.39% 37.38% 31.83% 28.06% 34.46%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
36.15% 40.98% 34.36% 54.30% 35.21% 36.55% 35.13% 41.22% 35.13% 31.49% 37.96%
Earnings before Interest and Taxes (EBIT)
3.60 40 3.14 -2.45 4.78 3.21 5.17 0.73 3.79 7.38 2.60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.82 41 4.43 -1.10 6.19 4.68 6.59 2.19 5.38 9.01 4.26
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.78 0.48 0.43 0.46 0.51 0.66 0.86 0.70 1.18 0.79 1.26
Price to Tangible Book Value (P/TBV)
1.28 0.60 0.54 0.59 0.64 0.81 1.05 0.85 1.48 0.97 1.53
Price to Revenue (P/Rev)
0.27 0.31 0.28 0.29 0.32 0.40 0.53 0.43 0.73 0.55 0.88
Price to Earnings (P/E)
0.00 0.00 2.87 0.98 1.15 9.85 10.36 5.96 10.58 4.23 8.15
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 34.85% 102.45% 86.64% 10.15% 9.65% 16.79% 9.45% 23.67% 12.27%
Enterprise Value to Invested Capital (EV/IC)
0.83 0.52 0.50 0.51 0.57 0.66 0.87 0.71 1.18 0.78 1.29
Enterprise Value to Revenue (EV/Rev)
0.37 0.37 0.37 0.34 0.40 0.40 0.54 0.43 0.73 0.49 0.83
Enterprise Value to EBITDA (EV/EBITDA)
0.00 25.57 2.47 1.02 1.19 4.55 5.58 3.81 6.90 3.86 7.16
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 3.23 1.13 1.33 7.44 8.53 5.39 10.07 5.24 10.28
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 15.13 15.37 8.47 14.04 5.48 12.85
Enterprise Value to Operating Cash Flow (EV/OCF)
8.81 11.05 11.81 5.07 7.32 5.07 7.04 7.13 6.60 4.03 5.94
Enterprise Value to Free Cash Flow (EV/FCFF)
1.50 0.00 0.00 0.00 0.00 8.68 13.77 44.13 21.14 0.00 390.61
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.12 0.07 0.08 0.08 0.08 0.07 0.06 0.06 0.07 0.06 0.05
Long-Term Debt to Equity
0.10 0.06 0.06 0.06 0.06 0.05 0.04 0.04 0.04 0.04 0.03
Financial Leverage
-0.03 -0.08 -0.05 -0.09 -0.06 -0.12 -0.09 -0.12 -0.10 -0.18 -0.17
Leverage Ratio
1.60 1.33 1.37 1.60 1.57 1.35 1.27 1.28 1.28 1.29 1.25
Compound Leverage Factor
1.59 1.32 1.33 1.67 1.54 1.31 1.26 1.16 1.24 1.28 1.23
Debt to Total Capital
10.78% 6.94% 7.38% 7.55% 7.04% 6.55% 5.93% 5.82% 6.28% 5.85% 4.77%
Short-Term Debt to Total Capital
2.28% 1.54% 2.03% 1.76% 1.72% 1.72% 1.75% 1.67% 2.51% 2.39% 1.52%
Long-Term Debt to Total Capital
8.50% 5.40% 5.35% 5.79% 5.32% 4.83% 4.18% 4.15% 3.77% 3.46% 3.25%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
23.47% 15.12% 14.75% 15.27% 14.72% 13.90% 13.75% 13.33% 12.52% 11.09% 12.56%
Common Equity to Total Capital
65.76% 77.94% 77.87% 77.18% 78.24% 79.55% 80.31% 80.85% 81.21% 83.06% 82.67%
Debt to EBITDA
-0.24 3.95 0.42 0.18 0.17 0.57 0.47 0.39 0.45 0.38 0.35
Net Debt to EBITDA
0.09 -4.15 -0.24 -0.20 -0.13 -1.25 -0.94 -0.90 -0.89 -1.20 -1.31
Long-Term Debt to EBITDA
-0.19 3.08 0.30 0.14 0.13 0.42 0.33 0.28 0.27 0.23 0.24
Debt to NOPAT
-5.48 -2.11 -2.25 -6.74 -52.62 1.91 1.28 0.87 0.92 0.55 0.62
Net Debt to NOPAT
2.05 2.21 1.30 7.35 40.79 -4.16 -2.59 -2.00 -1.81 -1.71 -2.35
Long-Term Debt to NOPAT
-4.32 -1.64 -1.64 -5.17 -39.76 1.41 0.90 0.62 0.55 0.32 0.42
Altman Z-Score
-0.97 0.53 -0.09 -0.23 0.21 0.45 1.11 0.86 1.88 1.53 2.91
Noncontrolling Interest Sharing Ratio
20.67% 16.47% 17.43% 20.99% 19.77% 15.54% 15.25% 15.26% 14.53% 13.17% 13.84%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.54 3.22 4.84 4.61 4.50 4.15 4.57 4.66 4.39 4.27 5.35
Quick Ratio
2.30 1.40 2.71 2.36 2.54 2.46 2.78 2.72 2.55 2.84 3.41
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
40 -1.43 -14 -42 -38 6.68 4.41 -12 0.41 -5.89 -11
Operating Cash Flow to CapEx
-92.03% 5,056.91% -1,528.46% 2,755.30% -626.40% 19,350.91% -364.75% 15,308.70% 0.00% 6,984.57% 250.49%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.06 0.98 1.01 1.06 1.06 1.07 1.14 1.18 1.16 1.10 1.09
Accounts Receivable Turnover
4.04 4.78 3.92 5.42 4.06 5.03 4.14 5.17 4.43 4.54 4.29
Inventory Turnover
2.33 2.21 2.21 2.11 2.21 2.30 2.42 2.41 2.45 2.71 2.64
Fixed Asset Turnover
6.17 0.00 6.10 6.23 6.50 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
9.82 12.61 10.75 11.53 10.86 12.52 9.58 11.69 13.52 12.38 9.64
Days Sales Outstanding (DSO)
90.36 76.34 93.12 67.40 89.84 72.61 88.08 70.56 82.43 80.31 85.00
Days Inventory Outstanding (DIO)
156.83 165.24 165.25 173.10 165.40 158.49 150.57 151.18 149.18 134.90 138.40
Days Payable Outstanding (DPO)
37.16 28.94 33.95 31.65 33.61 29.16 38.10 31.21 27.00 29.49 37.88
Cash Conversion Cycle (CCC)
210.03 212.64 224.41 208.85 221.63 201.94 200.55 190.53 204.61 185.72 185.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
66 101 105 99 107 98 105 106 110 115 116
Invested Capital Turnover
1.74 1.41 1.46 1.86 1.77 1.64 1.60 1.72 1.65 1.73 1.62
Increase / (Decrease) in Invested Capital
-38 -0.13 16 39 41 -3.17 -0.69 7.14 3.11 17 11
Enterprise Value (EV)
54 53 52 50 61 65 91 75 130 89 149
Market Capitalization
39 44 40 42 49 65 89 75 130 100 157
Book Value per Share
$20.75 $37.56 $37.70 $36.37 $38.37 $39.49 $40.60 $41.89 $43.35 $49.68 $49.04
Tangible Book Value per Share
$12.64 $29.51 $29.87 $28.66 $30.73 $31.93 $33.23 $34.58 $34.42 $40.88 $40.37
Total Capital
77 118 120 118 123 124 128 132 136 152 151
Total Debt
8.30 8.16 8.88 8.90 8.64 8.14 7.62 7.66 8.51 8.89 7.20
Total Long-Term Debt
6.54 6.34 6.44 6.83 6.53 6.00 5.37 5.46 5.11 5.26 4.91
Net Debt
-3.10 -8.56 -5.12 -9.71 -6.69 -18 -15 -18 -17 -28 -27
Capital Expenditures (CapEx)
0.44 0.12 0.12 0.22 0.32 0.06 0.45 0.02 -0.23 0.19 0.51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
61 56 62 55 64 56 64 64 64 60 63
Debt-free Net Working Capital (DFNWC)
72 73 76 74 79 82 87 89 89 97 97
Net Working Capital (NWC)
70 71 74 72 77 80 85 87 86 93 95
Net Nonoperating Expense (NNE)
-1.96 -41 -0.45 -0.07 -1.64 -0.21 -0.73 -6.87 -0.72 -4.51 -1.17
Net Nonoperating Obligations (NNO)
-3.10 -8.56 -5.99 -11 -7.47 -18 -16 -18 -17 -28 -28
Total Depreciation and Amortization (D&A)
1.22 1.27 1.29 1.35 1.41 1.47 1.42 1.45 1.59 1.64 1.66
Debt-free, Cash-free Net Working Capital to Revenue
41.10% 39.48% 43.54% 37.65% 41.97% 34.70% 38.19% 36.47% 36.00% 32.84% 35.12%
Debt-free Net Working Capital to Revenue
48.84% 51.22% 53.35% 50.31% 52.00% 50.62% 51.82% 50.93% 50.21% 52.84% 54.34%
Net Working Capital to Revenue
47.64% 49.95% 51.64% 48.90% 50.62% 49.31% 50.49% 49.68% 48.30% 50.86% 53.06%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.78 $16.07 $0.83 ($1.21) $1.63 $1.35 $1.58 $0.36 $1.47 $5.76 ($0.14)
Adjusted Weighted Average Basic Shares Outstanding
2.48M 2.47M 2.51M 2.55M 2.55M 2.54M 2.57M 2.59M 2.59M 2.59M 2.63M
Adjusted Diluted Earnings per Share
$1.77 $16.08 $0.82 ($1.21) $1.60 $1.34 $1.51 $0.34 $1.37 $5.43 ($0.14)
Adjusted Weighted Average Diluted Shares Outstanding
2.49M 2.47M 2.54M 2.55M 2.59M 2.59M 2.69M 2.73M 2.78M 2.75M 2.63M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.44M 2.49M 2.50M 2.50M 2.50M 2.54M 2.54M 2.54M 2.54M 2.55M 2.62M
Normalized Net Operating Profit after Tax (NOPAT)
1.31 -1.55 2.10 -2.91 2.13 2.06 3.73 -1.42 2.14 3.65 0.57
Normalized NOPAT Margin
3.43% -4.41% 4.79% -9.78% 4.83% 4.57% 7.45% -3.90% 4.61% 7.21% 1.26%
Pre Tax Income Margin
9.34% 113.21% 6.93% -8.65% 10.61% 6.92% 10.25% 1.83% 7.94% 14.49% 5.64%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% -16.07% 6.93% 2.29% 3.39% 25.19% 0.00% 16.81% 20.90% 10.37% 0.00%
Augmented Payout Ratio
0.00% -16.07% 6.93% 2.29% 3.39% 25.19% 0.00% 16.81% 20.90% 10.37% 0.00%

Financials Breakdown Chart

NCS Multistage Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NCS Multistage's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

NCS Multistage's net income appears to be on a downward trend, with a most recent value of $26.04 million in 2025, falling from $28.03 million in 2015. The previous period was $8.14 million in 2024. See NCS Multistage's forecast for analyst expectations on what's next for the company.

NCS Multistage's total operating income in 2025 was $10.54 million, based on the following breakdown:
  • Total Gross Profit: $75.43 million
  • Total Operating Expenses: $64.89 million

Over the last 10 years, NCS Multistage's total revenue changed from $114.01 million in 2015 to $183.63 million in 2025, a change of 61.1%.

NCS Multistage's total liabilities were at $38.10 million at the end of 2025, a 3.8% increase from 2024, and a 74.5% decrease since 2016.

In the past 9 years, NCS Multistage's cash and equivalents has ranged from $11.24 million in 2019 to $36.73 million in 2025, and is currently $36.73 million as of their latest financial filing in 2025.

Over the last 10 years, NCS Multistage's book value per share changed from 0.00 in 2015 to 49.68 in 2025, a change of 4,968.2%.



Financial statements for NASDAQ:NCSM last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners